Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Liver Biopsy Equipment Supplied In Europe
5 equipment items found
Manufactured by:ENDRA Life Sciences Inc. based inAnn Arbor, MICHIGAN (USA)
Thermo-Acoustic Enhanced UltraSound (TAEUS) combines radio frequency and ultrasound waves to measure fat in the liver in a groundbreaking way. ...
Manufactured by:Hemogenyx Pharmaceuticals plc based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals utilizes postnatal human hemogenic endothelial cells (Hu-PHEC cells), discovered by Hemogenyx Pharmaceuticals’ Co-Founder Dr Vladislav Sandler, to generate cancer-free hematopoietic stem cells (HSC) for use in transplants to treat blood cancers with superior results. A patent for Dr Sandler’s work was issued in the US in February ...
Manufactured by:BetaGlue Technologies SpA based inMilano, ITALY
Surgery is the standard of care for resectable solid tumors. Loco-regional approaches, in combination with chemotherapy and/or radiotherapy, are standard therapy in the following ...
Manufactured by:BetaGlue Technologies SpA based inMilano, ITALY
The Betaglue team has identified an area of unmet need and has developed a novel solution for the prevention of the complications occurring during percutaneous biopsy procedures in soft tissues, such as hemorrhage, pneumothorax (PNX) or tumor ...
Manufactured by:GENFIT based inLoos, FRANCE
Nonalcoholic steatohepatitis (NASH) remains largely underdiagnosed, as it carries no obvious symptoms in its early stages, and also because of the lack of widely available non-invasive tests specifically developed to diagnose the disease. The underdiagnosis of NASH represents a major unmet need, and is a barrier for identification of patients at higher risk for disease progression, who would be ...